Free tool
FAERS Monitor: Plasma-Lyte A In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017378 or its brand name (Plasma-Lyte A In Plastic Container, Magnesium Chloride, Potassium Chloride, Sodium Acetate, Sodium Chloride, Sodium Gluconate). Reports on generic versions are filed under their own applications.
Reports
59
Serious
55
93% of reports
Hospitalization
24
Death reported
11
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- acute kidney injury6
- emotional distress6
- pain6
- renal failure6
- respiratory failure6
- anxiety5
- injury5
- pyrexia5
- constipation4
- death4
- pneumonia4
- pruritus4
- renal injury4
- sepsis4
- acinetobacter infection3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 4 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 9 |
| 2021 | 1 |
| 2022 | 7 |
| 2023 | 12 |
| 2024 | 3 |
| 2025 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,100 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acinetobacter infectionSignal | 3 | 980.4 | 325.0 | 2,032 |
| renal injurySignal | 4 | 48.0 | 18.6 | 140 |
| respiratory failureSignal | 6 | 29.3 | 13.7 | 138 |
| injurySignal | 5 | 25.4 | 11.0 | 94 |
| emotional distressSignal | 6 | 17.7 | 8.3 | 79 |
| renal failureSignal | 6 | 16.1 | 7.5 | 71 |
| acute kidney injurySignal | 6 | 14.0 | 6.5 | 60 |
| sepsisSignal | 4 | 12.8 | 5.0 | 33 |
| constipationSignal | 4 | 6.5 | 2.5 | 14 |
| anxietySignal | 5 | 6.3 | 2.7 | 17 |
| pyrexiaSignal | 5 | 5.2 | 2.2 | 13 |
| pneumoniaSignal | 4 | 4.4 | 1.7 | 8 |
| pruritusSignal | 4 | 3.7 | 1.4 | 6 |
| painSignal | 6 | 3.5 | 1.6 | 9 |
| death | 4 | 1.7 | 0.6 | 1 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.